Project Grant HT94252510123
Award Date
3/1/25
Completion Date
2/28/27
Dollars Obligated
$2.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90033, USA
Similar Awards
The University of Southern California (USC) received a $1,992,000.00 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 15, 2025 to September 14, 2028, supports the development of a synthetic immune receptor for the treatment of prostate cancer. As a leading research university, USC will leverage its expertise in areas such as biomedical...
The University of Southern California will receive $330,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health care. Through this funding, USC will validate PIKFYVE inhibition as a therapeutic approach for diverse forms of frontotemporal dementia from March 2021 to...
The Department of the Army Medical Command awarded a $1,180,437 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports UCLA's research to evaluate circulating cell-free DNA as a biomarker for diagnosing and tracking the progression of amyotrophic lateral sclerosis (ALS). The award began on March 1, 2024 and is scheduled for completion by February 28, 2026. Through this Project Grant, UCLA...
The University of Southern California (USC) was awarded a $3,296,634.00 Project Grant from the Defense Health Agency to conduct research on "ACTIVATION OF BRAIN LYMPHATIC DRAINAGE THROUGH PIEZO1-CONTROLLED MECHANOTRANSDUCTION AS A NOVEL HYDROCEPHALUS THERAPY". The grant, which commenced on September 1, 2023 and will be completed by August 31, 2027, is funded through the Military Medical Research and Development (CFDA 12.420) program. This research aims to investigate medical...
The University of Southern California will receive $1,209,550 under a three-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve health care for service members and the public. Specifically, USC will develop wearable early intervention electric stimulation technology for optic nerve regeneration. The...
The University of Southern California (USC) Department of Contracts and Grants Division was awarded a $331,630 Project Grant by the Defense Health Agency under the "Military Medical Research and Development" (CFDA 12.420) program. The grant supports research into mRNA delivery for polycystic kidney disease, with a period of performance from November 15, 2023 to November 14, 2025. As a leading private research university, USC leverages its expertise in engineering, health sciences,...
The University of Southern California (USC) received a $828,538 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MICRORNA THERAPY TARGETING FIBROTIC SCAR FORMATION FOR IMPROVEMENT OF COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY". The award has a performance period from May 1, 2024 to April 30, 2027. The funded research aims to develop novel microRNA-based therapies to address fibrotic...
This $1,181,251 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research to develop neuronal exosome-based biomarkers for amyotrophic lateral sclerosis (ALS) diagnosis and disease progression. The prime awardee is the University of California, Los Angeles (UCLA), which will leverage its extensive medical research facilities, faculty expertise, and administrative capabilities to conduct this...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This federal Project Grant award, valued at $1,103,084.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports the development of a personalized blood-based diagnostic assay for early detection of Amyotrophic Lateral Sclerosis (ALS) at Arizona State University. The university will collaborate with a sub-awardee, Georgetown University, to conduct the research. The project aims to transform healthcare for...